Jan De Pooter

Jan De Pooter

Auto-generated profile, based on publicly available information

Jan De Pooter

Department of Cardiology, Ghent University Hospital, Ghent, Belgium

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2025 in EP Europace
Verified
Journal Article
Open access
MGMichael Glikson
Michael Glikson
HBHaran Burri
Haran Burri
AAAmr Abdin
Amr Abdin
ÓCÓscar Cano
Óscar Cano
KCkarol curila
karol curila
NVNiraj Varma
Niraj Varma
Conduction system pacing (CSP) is being increasingly adopted as a more physiological alternative to right ventricular and biventricular pacing. Since the 2021 European Society of Cardiology pacing guidelines, there has been growing evidence that this therapy is safe and effective. Furthermore, left bundle branch area pacing was not covered in these guidelines due to limited evidence at that time. This Clinical Consensus Statement provides advice on indications for CSP, taking into account the significant evolution in this domain.

1 March 2019 in JACC: Clinical Electrophysiology
Verified
Journal Article
Closed access
JPJan De Pooter
Jan De Pooter
TSTeresa Strisciuglio
Teresa Strisciuglio
MHMilad El Haddad
Milad El Haddad
MWMichael Wolf
Michael Wolf
TPThomas Phlips
Thomas Phlips
MDMattias Duytschaever
Mattias Duytschaever

1 April 2020 in Heart Rhythm
Verified
Journal Article
Closed access
MDMattias Duytschaever
Mattias Duytschaever
JPJan De Pooter
Jan De Pooter
ADAnthony Demolder
Anthony Demolder
MHMilad El Haddad
Milad El Haddad
TPThomas Phlips
Thomas Phlips
RTRene Tavernier
Rene Tavernier

23 December 2020 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
PDF file
JPJan De Pooter
Jan De Pooter
SCSimon Calle
Simon Calle
FTFrank Timmermans
Frank Timmermans
FHFrederic Van Heuverswyn
Frederic Van Heuverswyn

21 February 2022 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
JPJan De Pooter
Jan De Pooter
AWAurelien Wauters
Aurelien Wauters
FHFrederic Van Heuverswyn
Frederic Van Heuverswyn
JWJean-Benoit Le Polain de Waroux
Jean-Benoit Le Polain de Waroux
Left bundle branch area pacing (LBBAP) has emerged as a novel pacing modality which aims to capture the left bundle branch area and avoids the detrimental effects of right ventricular pacing. Current approaches for LBBAP have been developed using lumen-less pacing leads (LLL). Expanding the tools and leads for LBBAP might contribute to a wider adoption of this technique. Standard stylet-driven pacing leads (SDL) differ from current LLL as they are characterized by a wider lead body diameter, are stylet-supported and often have a non-isodiametric extendable helix design. Although LBBAP can be performed safely with SDL, the implant technique of LBBAP differs compared to LLL. In the current overview we describe in detail how different types of SDL can be used to target a deep septal position and provide a practical guide on how to achieve LBBAP using SDL.

22 September 2025 in European Heart Journal
Verified
Journal Article
Open access
MJMarek JastrzęBski
Marek JastrzęBski
GKGrzegorz Kiełbasa
Grzegorz Kiełbasa
ÓCÓscar Cano
Óscar Cano
KCkarol curila
karol curila
FZFrancesco Zanon
Francesco Zanon
HBHaran Burri
Haran Burri
Background and Aims: Left bundle branch area pacing (LBBAP) promotes physiological synchronous activation of the left ventricle and may be particularly beneficial in patients with atrioventricular block (AVB), but its mortality benefit remains unclear. This study aims to compare long-term survival in AVB patients receiving either LBBAP or right ventricular pacing (RVP) and to analyse predictors of mortality during LBBAP. Methods: MELOS RELOADED, a multicentre European collaboration, was a registry-based study of pacemaker patients with AVB, left ventricular ejection fraction (LVEF) >40% and ventricular pacing >20%. The primary outcome was all-cause mortality based on national registries. A 1:1 propensity score matching was performed between the RVP and LBBAP groups. Kaplan–Meier curves and multivariable Cox proportional hazards models were used to estimate survival. Results: In total, 3382 patients receiving LBBAP or RVP were matched. At 4-year follow-up, the Kaplan–Meier curve showed an absolute difference in survival of 11.8% in favour of LBBAP (P < .001). LBBAP was a robust predictor of reduced mortality with a hazard ratio (HR) of 0.53 (95% confidence interval 0.42–0.65, P < .001). Within the LBBAP group, the following independent predictors of increased mortality were identified: lack of confirmed left bundle branch capture (HR 1.85, P < .001), lower percentage of ventricular pacing (HR 1.12), and age. Conclusions: This is the first large study demonstrating the long-term survival benefit of LBBAP. This strengthens the use of LBBAP in AVB patients with preserved/mildly reduced LVEF while awaiting the results of randomized trials. Confirmation of left bundle branch capture seems advisable to achieve optimal results with LBBAP.